Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
- 14 August 2010
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 46 (1) , 92-100
Abstract
Noninvasive risk factors are required for predicting the development of hepatocellular carcinoma (HCC) not only in patients with cirrhosis but also in those with chronic hepatitis who are infected with hepatitis C virus (HCV).Keywords
This publication has 57 references indexed in Scilit:
- Clinical significance of elevated alpha‐fetoprotein in Alaskan Native patients with chronic hepatitis CJournal of Viral Hepatitis, 2007
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohortsJournal of Hepatology, 2006
- A Decrease in AFP Level Related to Administration of Interferon in Patients with Chronic Hepatitis C and a High Level of AFPDigestive Diseases and Sciences, 2006
- Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C TrialJournal of Hepatology, 2005
- Culture Systems for Hepatitis C Virus in Sight at LastScience, 2005
- The Natural History of Hepatitis CSeminars in Liver Disease, 2004
- Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis CJournal of Antimicrobial Chemotherapy, 2003
- Role of liver biopsy in management of chronic hepatitis C: A systematic reviewHepatology, 2002
- Platelet count reflects stage of chronic hepatitis CHepatology Research, 1999